[go: up one dir, main page]

BRPI0816364B8 - solução de injeção, preparação de kit de injeção e injetável para preparar solução de injeção - Google Patents

solução de injeção, preparação de kit de injeção e injetável para preparar solução de injeção

Info

Publication number
BRPI0816364B8
BRPI0816364B8 BRPI0816364A BRPI0816364A BRPI0816364B8 BR PI0816364 B8 BRPI0816364 B8 BR PI0816364B8 BR PI0816364 A BRPI0816364 A BR PI0816364A BR PI0816364 A BRPI0816364 A BR PI0816364A BR PI0816364 B8 BRPI0816364 B8 BR PI0816364B8
Authority
BR
Brazil
Prior art keywords
injection
injectable
injection solution
solution
prepare
Prior art date
Application number
BRPI0816364A
Other languages
English (en)
Inventor
Miyoshi Akiko
Ota Masato
Yoshizawa Teruhisa
Original Assignee
Meiji Seika Kaisha
Meiji Seika Pahrma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha, Meiji Seika Pahrma Co Ltd filed Critical Meiji Seika Kaisha
Publication of BRPI0816364A2 publication Critical patent/BRPI0816364A2/pt
Publication of BRPI0816364B1 publication Critical patent/BRPI0816364B1/pt
Publication of BRPI0816364B8 publication Critical patent/BRPI0816364B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

injetável, solução de injeção e kit de preparação da injeção. a presente invenção refere-se a um injetável compreendendo: um antibiótico antineoplásico de antraciclina; e pelo menos uma amida de ácido selecionada a partir do grupo que consiste em amida do ácido nicotínico, amida do ácido isonicotínico e etanolamida do ácido gentísico.
BRPI0816364A 2007-09-04 2008-09-03 solução de injeção, preparação de kit de injeção e injetável para preparar solução de injeção BRPI0816364B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007228516 2007-09-04
JP2007-228516 2007-09-04
PCT/JP2008/065865 WO2009031577A1 (ja) 2007-09-04 2008-09-03 注射剤、注射液および注射用キット製剤

Publications (3)

Publication Number Publication Date
BRPI0816364A2 BRPI0816364A2 (pt) 2015-09-29
BRPI0816364B1 BRPI0816364B1 (pt) 2020-10-13
BRPI0816364B8 true BRPI0816364B8 (pt) 2021-05-25

Family

ID=40428891

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0816364A BRPI0816364B8 (pt) 2007-09-04 2008-09-03 solução de injeção, preparação de kit de injeção e injetável para preparar solução de injeção

Country Status (9)

Country Link
US (1) US8227430B2 (pt)
EP (1) EP2184066B1 (pt)
JP (1) JP4456177B2 (pt)
KR (1) KR101511398B1 (pt)
CN (1) CN101795694B (pt)
BR (1) BRPI0816364B8 (pt)
ES (1) ES2439497T3 (pt)
MX (1) MX2010001263A (pt)
WO (1) WO2009031577A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂
WO2013154045A1 (ja) * 2012-04-09 2013-10-17 日本マイクロバイオファーマ株式会社 注射剤用組成物
JP7001454B2 (ja) * 2017-12-18 2022-01-19 日本化薬株式会社 ホスアプレピタントを含有する医薬製剤
LU101511B1 (en) * 2019-12-02 2021-06-04 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a parenteral administration and a process for the preparation of an injectable substance

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB485569A (en) * 1936-11-17 1938-05-17 Ig Farbenindustrie Ag Process for the manufacture of stable solutions of the polyoxyalkylisoalloxazines
JPS58105917A (ja) * 1981-12-21 1983-06-24 Toa Eiyou Kagaku Kogyo Kk イソソルビド硝酸エステル溶液
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
FI91710C (fi) * 1986-12-05 1994-08-10 Erba Carlo Spa Menetelmä injektoitavan käyttövalmiin, säilytystä kestävän, steriilin antrasykliiniglykosidiliuoksen valmistamiseksi
US4875311A (en) * 1988-04-20 1989-10-24 Sun Room Designs, Inc. Beam construction
JP2919112B2 (ja) 1991-05-13 1999-07-12 武田薬品工業株式会社 セファロスポリン注射剤およびその製造法
JP2915252B2 (ja) 1993-06-30 1999-07-05 明治製菓株式会社 溶解性が改善された製剤の製造法
TW280770B (pt) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
JPH09124503A (ja) 1995-10-27 1997-05-13 L T T Kenkyusho:Kk アミチアマイシン類の注射用の抗菌性組成物
JP2000212088A (ja) * 1999-01-27 2000-08-02 Kobayashi Kako Kk 難溶性抗ウイルス剤の水溶液
KR100405161B1 (ko) 2000-12-14 2003-11-12 신풍제약주식회사 록소프로펜 함유 근육주사제 조성물
US6881726B2 (en) * 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
JP2003261449A (ja) * 2002-03-05 2003-09-16 Nisshin Oillio Ltd ファモチジン含有水性注射剤およびその製造法
JP2004010479A (ja) * 2002-06-03 2004-01-15 Japan Science & Technology Corp ブロック共重合体とアンスラサイクリン系抗癌剤を含む新規固型製剤及びその製造法
JP2004051526A (ja) 2002-07-18 2004-02-19 Nippon Shokubai Co Ltd 多価フェノールの製造方法
EP1695973A1 (en) * 2005-02-24 2006-08-30 Neuro3D Ocaperidone salt and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
EP2184066B1 (en) 2013-11-06
US20100173862A1 (en) 2010-07-08
HK1142820A1 (en) 2010-12-17
WO2009031577A1 (ja) 2009-03-12
EP2184066A1 (en) 2010-05-12
KR20100051694A (ko) 2010-05-17
JPWO2009031577A1 (ja) 2010-12-16
CN101795694A (zh) 2010-08-04
BRPI0816364B1 (pt) 2020-10-13
JP4456177B2 (ja) 2010-04-28
ES2439497T3 (es) 2014-01-23
MX2010001263A (es) 2010-10-04
CN101795694B (zh) 2012-10-10
EP2184066A4 (en) 2012-08-01
US8227430B2 (en) 2012-07-24
BRPI0816364A2 (pt) 2015-09-29
KR101511398B1 (ko) 2015-04-24

Similar Documents

Publication Publication Date Title
AR111811A2 (es) Compuestos derivados de 1,2,4-oxadiazol y composiciones para el control de nematodos
BRPI0923702B8 (pt) Composições inseticidas estáveis compreendendo spinosin e uma mistura esteroisomérica de sulfoxaflor, e seu método de produção
BR112015015031A2 (pt) processo de glicoconjugação
BR112013030253A2 (pt) compostos com grupos de éster de oxima e/ou acila
BR112014009790A2 (pt) composto para modulação antisense da expressão de gccr, seu uso e composição
BRPI0611872B8 (pt) reagente polimérico, conjugado, método para preparação de um conjugado e composição farmacêutica
BR112014012524A2 (pt) composições compreendendo um componente de estabilidade do prazo de validade
BR112016004023A2 (pt) Composição, métodos para preparar uma composição e para tratar uma doença, e, composto
NO20091509L (no) Substituerte tetrahydropyrrolopyrazinforbindelser med affinitet KCNQ2/3 K+ kanal og anvendelse derav i medikamenter
BR112012024432A2 (pt) composição farmacêutica de dissolução rápida
EA201791850A1 (ru) Борсодержащие малые молекулы
BR112015030918A2 (pt) método para produção de células progenitoras renais, e fármacos contendo células progenitoras renais
BR112015001414A2 (pt) composição antideriva
BRPI0715408B8 (pt) Processo para a preparação de 5-(1-alquiltio)alquilpiridinas 2-substituída
BRPI0703525A (pt) composições de toner
BRPI0911511B8 (pt) formulação de dna liofilizadas para aumentar a expressão de dna de plasmídeo
BR112015012972A2 (pt) método para tratar uma formação subterrânea, composição para tratamento de uma formação subterrânea, e, método para preparo de uma composição aquosa para tratamento de uma formação subterrânea
UY31712A1 (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen
BR112013022213A2 (pt) administração parenteral de tapentadol
BR112013020873A2 (pt) endoprótese e método para revestimento de uma endoprótese
BR112016013316A8 (pt) método para a produção de furfural e uso de ácido metanossulfônico
BRPI0816364B8 (pt) solução de injeção, preparação de kit de injeção e injetável para preparar solução de injeção
BR112012014621A2 (pt) processo para a preparação de compostos de quelato
BR112015012453A2 (pt) método e composição para sincronizar o tempo de inseminação em leitoas
BRPI0820494A8 (pt) Métodos para preparar capecitabina e composto de carbonato de trialquila rico em beta-anômero usado no mesmo

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: MEIJI SEIKA PAHRMA CO., LTD. (JP)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/09/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2738 DE 27-06-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.